A simulated surveillance program for bovine paratuberculosis in dairy herds in Norway

Monte Carlo simulation models were used to evaluate the feasibility and potential results of a proposed national survey of the prevalence of bovine paratuberculosis (PTB) in dairy herds in Norway. The expected herd prevalence was assumed to be 0.2% in the simulations. The low sensitivity of the ELISA test, the assumed low herd prevalence, the typical low within-herd prevalence of PTB and the small herd sizes all present problems in detection of the disease. Simulations with 500, 1000, 2500 and 6000 herds tested were done. Our results suggest that a national survey would not be feasible at present, due to the low probability of detecting infected herds and because of the high number of false-positive reactions that would be expected to occur.     

Genomic and Pathogenic Studies on a Glycoprotein E Variant Field Isolate of Bovine Herpesvirus 1

Glycoprotein E-negative (gE–) laboratory strains of bovine herpesvirus 1 (BHV-1) were recently introduced as novel marker vaccines, allowing serological discrimination between vaccinated and naturally infected animals on the basis of lack or presence of antibodies against gE epitopes. The applicability of this approach is based on the genetic stability of the gE. However, mutant field variants of BHV-1 with a variable response in anti-gE ELISA have been isolated. The molecular characterization of a gE variant field isolate (Salwa strain) is presented here. By comparing the gE nucleotide and amino acid sequences of the Salwa strain with those of the wild strain Jura, ten mutated bases were found in the gE strain of Salwa, six of which alter the amino acid sequence, leading to changes in five amino acids. Both strains caused respiratory disease in experimentally infected calves, but Salwa generated slightly milder signs. Both viruses were excreted in nasal and ocular discharges, and were reactivated by dexamethasone treatment. In conclusion, the rather close similarities observed in the gE gene structure and pathogenicity features of the gE mutant and of the wild strain of BHV-1 confirm the genetic stability of gE. The findings indicate that the Salwa isolate is virulent, but less virulent than wild strains. Our data support the use of gE-negative marker vaccines in eradication programmes.     

夹心ELISA快速检测蓖麻粕中残留的蓖麻毒素

通过实验建立了蓖麻粕中残留蓖麻毒素的夹心ELISA检测方法(双抗原夹心法)。蓖麻粕样品经pH值7.4的磷酸盐缓冲液(PBS)提取,使蓖麻毒素充分溶出后可直接用于ELISA检测。在本文确定的实验条件下,蓖麻粕中杂质对蓖麻毒素的检测无显著影响;方法检出限小于2.5ng/ml,以蓖麻毒素浓度(5～80ng/ml)对数做校准曲线,R2=0.995。经高压灭菌锅0.1MPa处理1h的蓖麻粕中未检出蓖麻毒素,并以此作为蓖麻粕的阴性对照,对实际样品进行了测定。     

鸡肝脏和肌肉组织中常山酮残留的ELISA检测

将常山酮进行人工改造,制备了半抗原常山酮琥珀酸衍生物（Hal-suc）.采用N-羟基琥珀酰亚胺活性酯法将半抗原与牛血清白蛋白（BSA）、卵清白蛋白（OVA）偶联,制备免疫原和包被原.动物免疫6次后采血制备抗血清,以间接ELISA法测定血清效价,测得抗血清的最佳工作浓度为1∶102 400.建立了常山酮在鸡肝脏和肌肉组织中检测的ELISA法,该方法在50、100、500 ng/g 的添加浓度水平下,在鸡肝脏和肌肉组织中测得的平均回收率范围分别为74.2%～96.8%和74.3%～90.0%,检测限分别为28和19 ng/g.     

牛分枝杆菌抗原MPB70、MPB83和ESAT-6的融合表达及重组蛋白的初步应用

应用PCR方法从牛分枝杆菌Vallee株基因组中扩增获得mpb70、mpb83和esat-6三个目的基因片段。采用重叠延伸剪接技术(splicing by overlap extension,SOE)获得融合基因mpb70-mpb83后,将mpb70-mpb83和esat-6串连于同一表达载体pET32a( )中得到重组质粒pET70-83-E6。转化BL21(DE3)大肠杆菌感受态后,经IPTG诱导以可溶的形式表达融合蛋白。用Ni2 亲合层析的方法纯化该融合蛋白。Western blot分析显示:该融合蛋白能与抗牛分枝杆菌阳性血清发生特异性反应,而与牛副结核病阳性血清不反应。用该纯化蛋白初步建立了间接ELISA方法,并检测了117份临床血清样本(其中67份为PPD阳性牛血清),阳性率为39.32%(46/117)份,与PPD皮试诊断的符合率为82.05%(96/117)。     

猪传染性胸膜肺炎重组亚单位疫苗诱导小鼠免疫保护效果的观察

重组表达猪传染性胸膜肺炎放线杆菌6种主要毒力因子基因:apxⅠ、apxⅡ、apxⅢ、apxⅣ、apfa和omp,以重组蛋白rApxⅠ、rApxⅡ、rApxⅢ和rOMP组合免疫小鼠作为试验I组,重组蛋白rApxⅠ、rApxⅡ、rApxⅢr、OMPr、ApxⅣ和rApfa组合免疫小鼠作为试验Ⅱ组,PBS为对照组,分3次免疫小鼠,采用背部皮下多点注射,每次间隔2周,免疫剂量为0.2 mL/只,3免后1周分别以APP1型菌Shope 4074株(5×109cfu)和APP2型菌S1536株(5×1010cfu)进行攻毒试验。通过小鼠保护率与抗体效价的相关性研究、肺部病理变化及肺脏细菌的分布情况等指标进行综合评价。结果显示,试验Ⅰ组4种重组蛋白特异性抗体水平显著高于其他两组(P<0.05),对APP1型菌攻毒的保护率(9/10)明显高于试验Ⅱ组(5/10)和对照组(0/8),小鼠的免疫保护率与抗体效价之间存在显著正相关;且该组对APP2型菌攻毒的保护作用(无肺脏损伤)也明显优于其它两组(典型肺部损伤)。间接免疫荧光试验表明试验Ⅰ组对肺脏细菌的清除效果也明显优于其他两组。本试验揭示试验Ⅰ组对不同血清型APP攻击能够提供很好的交叉保护作用,从而为猪传染性胸膜肺炎新型疫苗的研制提供参考。     

新孢子虫dNcSRS2重组蛋白间接ELISA的建立及其应用

利用新孢子虫体外重组表面蛋白dNcSRS2蛋白作为包被抗原，对各项条件进行优化，确定判定标准，建立了检测新孢子虫血清抗体的间接ELISA方法。经对多例血清检测表明，所建立的诊断试剂盒重复性好、特异性强、灵敏度高，与进口的IFAT及两种商品化ELISA试剂盒的检测结果相比较，符合率均达到92％以上。应用建立的ELISA方法对236份奶牛血清的新孢子虫抗体进行检测，阳性率为22％。这是国内首次利用重组蛋白建立的诊断试剂盒，该方法的建立将为牛新孢子虫病的诊断与流行病学调查提供有效的技术手段。     

广东部分地区中小型猪场猪伪狂犬病野毒感染的血清学调查

采用阻断ELISA法,对广东省9个地区经猪伪狂犬基因缺失苗免疫的中小型猪场2005年-2006上半年送检的375份血清进行猪伪狂犬病野毒感染的血清学检测。结果表明,有9个地区猪场血清呈阳性,其中阳性血清174份,平均阳性率为46.4%,最高阳性率达65.0%,提示该地区中小型猪场有猪伪狂犬病野毒感染。     

赤羽病病毒核衣壳蛋白抗体间接ELISA检测方法的建立

以纯化的重组赤羽病病毒核衣壳蛋白作为诊断抗原，建立了检测牛血清特异性核衣壳蛋白抗体的间接ELISA方法，初步组装成便于现地使用的试剂盒。经对试验条件进行优化，确定最佳抗原包被量为每孔1μg（100μL），样品稀释度为1：100，兔抗牛IgG辣根过氧化物酶标记抗体稀释度为1：8000。经特异性试验和重复性试验证明该方法特异性高、重复性好。应用初步研制的间接ELISA试剂盒和微量中和试验法分别对云南省的89份、内蒙古的100份牛血清样本进行了检测，以中和试验为参照，经统计学处理，得出检测临界值分别为0．411和0．303，2种方法的符合率分别为72．7％（56／77）和91．4％（85／93）。试剂盒在37℃保存3d，对敏感性无明显影响。     

禽呼肠孤病毒P17蛋白基因在大肠杆菌中的表达及其ELISA检测方法的建立

用设计合成的1对跨越禽呼肠孤病毒（ARV）P17非结构蛋白基因完整开放阅读框（ORF）的特异性引物，对ARVS1133株进行了RT-PCR扩增。扩增产物与pGEX-4T-1原核表达载体连接后，转化大肠杆菌BL21感受态细胞。经0．2mmol／LIPTG诱导，表达的融合蛋白分子质量为42.4ku，占茵体总蛋白的34％。表达产物P17蛋白经不同浓度尿素纯化后，纯度达到85％。Western-blotting显示，纯化的P17蛋白能与感染ARV的阳性血清反应，说明其具有抗原性。以此重组蛋白为包被抗原初步建立了用于鉴别检测ARV活病毒感染与灭活疫苗免疫的SPF鸡血清的ELISA。